Skip to main content
. 2021 Dec 6;43(7):1881. doi: 10.1038/s41401-021-00834-x

Fig. 5.

Fig. 5

d Representative immunoblots showing LC3 and Beclin-1 from HCT116 cells treated with either 2DG (5 mM) and different concentrations of lovastatin or lovastatin (10 μM) and different concentrations of 2DG for 48 h.